Kefah Mokbel: Rethinking Anthracyclines in HER2+ Breast Cancer
Kefah Mokbel, Chair of Breast Cancer Surgery at London Breast Institute and Honorary Professor of Medicine at Cardiff University School of Medicine, shared a post on LinkedIn: “Anthracyclines in…
Read the full articleYou might also wanna read
Safety of Breast-Conserving Surgery for Multifocal or Multicentric Breast Cancer
Conditions : Breast Cancer Interventions : Other: Breast-conserving surgery, postoperative radiotherapy and individualized adjuvant systemic
Performance of Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early Triple-Negative Breast Cancer
Conditions : Breast Cancer (Triple Negative Breast Cancer (TNBC)) Interventions : Other: Non interventional study Sponsors : Assistance Publ
Research on AI Models for Predicting Breast Cancer Treatment Effectiveness to Guide Her-2 Targeted ADC Therapy
Conditions : Breast Cancer Sponsors : Zhejiang Cancer Hospital Not yet recruiting
Anticancer 'nanoswitch' technology shows promise in animal model of triple-negative breast cancer, colorectal cancer
A research team led by Professor Yoosoo Yang (Department of Integrative Biotechnology) of Sungkyunkwan University, in collaboration with the
A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region
Conditions : Chronic Myeloid Leukemia Sponsors : Novartis Pharmaceuticals Not yet recruiting
Robotic-Assisted Versus Endoscopic-Assisted Axillary Lymph Node Dissection in Breast Cancer
Conditions : Breast Neoplasms Sponsors : Guangzhou Women and Children's Medical Center Active, not recruiting
Comments
Sign in to join the conversation.
No comments yet. Be the first.